Pharma tries to recoup public trust

RSS
Stung by Public Distrust, Drug Makers Seek to Heal Image: "'The decision against Merck...is a clear statement that despite all the good our industry is doing, we're losing the battle for consumer trust,' says Arthur Higgins, chairman of Bayer Healthcare, a Bayer AG unit."


And they're working on it, but this will be a tough one to come back from—only 21 percent of people surveyed give pharma a favorable rating, according to the article in the Wall St. Journal (free for seven days).

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×